Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Clinical Impact of the Decipher Genomic Classifier in Prostate Cancer

5 May 2025

Abstract excerpt

The Decipher genomic classifier (GC) is a 22-gene expression test that refines risk stratification and informs treatment decisions in localized prostate cancer. Traditional clinicopathologic factors, including prostate-specific antigen levels and kinetics, Gleason score, histologic variants, and tumor stage, do not fully capture disease heterogeneity, leading to potential overtreatment or undertreatment. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Molecular Biology Techniques and Applications
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40390327
DOI: 10.5152/eurasianjmed.2025.25828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Clinical Impact of the Decipher Genomic Classifier in Prostate CancerPMID 40390327Read ↗

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patientsSemantic proximity Read ↗

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate CancerSemantic proximity Read ↗

Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier.Semantic proximity Read ↗

Genomic Profiling of Prostate Cancer: An Updated ReviewSemantic proximity Read ↗

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerSemantic proximity Read ↗

Genomic Classifiers and Prognosis of Localized Prostate Cancer: A Systematic ReviewSemantic proximity Read ↗

Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancerSemantic proximity Read ↗

Evaluation of Post Robotic Prostatectomy Genomic Analysis for Predicting Prostate Cancer Specific MortalitySemantic proximity Read ↗

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity Read ↗

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseSemantic proximity Read ↗

The Diverse Genomic Landscape of Clinically Low-risk Prostate CancerSemantic proximity Read ↗

A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.